StockData
Zeo ScientifiX, Inc. logo

Zeo ScientifiX, Inc. (ZEOX) stock

ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)

Close on Oct 19, 2026Market cap $7.08MP/E –Yield –

Earnings

Zeo ScientifiX's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$2.58M
EPS, Q2 FY2026
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Zeo ScientifiX's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Apr 30, 2026Jul 8, 2026before the open$2.58M––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Zeo ScientifiX has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Zeo ScientifiX puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Zeo ScientifiX filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. News
  5. News
  6. Results
  7. News
  8. News
  9. News
  10. News
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?